No Detail Found!

Value of erythrocyte sedimentation rate and serum epo levels in evaluating the condition and prognosis of COPD in the elderly

Author(s)
Linxuan Wang Department of Pulmonary and Critical Care Medicine, Shanghai Pudong New Area People's Hospital,Shanghai,China
Hua Yang Department of Pulmonary and Critical Care Medicine, Shanghai Pudong New Area People's Hospital,Shanghai,China
Wenchao Gu Department of Pulmonary and Critical Care Medicine, Shanghai Pudong New Area People's Hospital,Shanghai,China
Abstract
To investigate the value of erythrocyte sedimentation rate (ESR) and serum EPO levels in evaluating the condition and prognosis of chronic obstructive pulmonary disease (COPD) in the elderly. 120 elderly patients with acute exacerbation of COPD admitted to our hospital from May 2016 to April 2019 were selected. Pulmonary function tests and CT scans were performed on all patients. According to Gold's guidelines for the diagnosis and treatment of chronic obstructive pulmonary disease, patients with different degrees of illness were divided into mild group, moderate group and severe group. The levels of EPO and ESR were measured in the morning after admission and the differences of EPO and ESR between the three groups were compared. The correlation between EPO, ESR and FEV1% of lung function index was analyzed by linear correlation analysis. There was no significant difference in age, sex, BMI index and course of disease among the three groups (P>0.05); ESR and EPO increased in turn among mild, moderate and severe groups, while FEV1% decreased in turn, with significant differences between the two groups (P<0.05). Negative correlation (r values were - 0.33, - 0.49, P<0.05). ESR and serum EPO levels can reflect the severity of COPD in elderly patients to some extent, and are negatively correlated with FEV1% of lung function indicators, which can provide some clues to the condition and prognosis of COPD in elderly patients.
Publication Details
Page(s) 435-439
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 34, Issue: S1, Year: 2021

Request the full text from PASTIC

Keywords
elderly COPD, Condition, erythrocyte sedimentation rate, serum EPO, prognosis
References
Barnes PJ .2016 .Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J. Allergy. Clin. Immunol, 138(1) : 16-27.
Barnes PJ .2018 .Targeting cytokines to treat asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol., 18(7) : 454-466.
Barouchos N,Papazafiropoulou A,Iacovidou N,Vrachnis N,Barouchos N,Armeniakou E,Dionyssopoulou V,Mathioudakis AG,Christopoulou E,Koltsida S,Bassiakou E .2015 .Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations. Scand J Clin. Lab, 75(2) : 126-32.
Barrett NA,Kostakou E,Hart N Douiri A and Camporota L E .2019 .Extracorporeal carbon dioxide removal for acute hypercapnic exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial. Trials, 20(1) : 465.
Cassady SJ,Reed RM .2019 .Pulmonary Hypertension in COPD: A Case Study and Review of the Literature. , 55(8) : 432.
Dean E .2017 .Chronic obstructive pulmonary disease. Nurs. Older People, 29(4) : 12.
Duffy SP,Criner GJ .2019 .. Chronic Obstructive Pulmonary Disease: Evaluation and Management. Med. Clin. North. Am., 103(3) : 453-461.
Fathy EM,Shafiek H,Morsi TS,El Sabaa B,Elnekidy A,Elhoffy M,Atta MS. .2016 .Image-enhanced bronchoscopic evaluation of bronchial mucosal microvasculature in COPD. Int. J. Chron. Obstruct. Pulmon. Dis., 11 : 2447.
Halpin DM,Miravitlles M,Metzdorf N,Celli B .2017 .Impact and prevention of severe exacerbations of COPD: A review of the evidence. Int J Chron Obstruct. Pulmon. Dis., 12 : 2891-2908.
Jin J,Yu W,Li S,Lu L,Liu X,Sun Y. .2016 .Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease. Medicine (Baltimore), 95(29) : e4219.
Lareau SC,Fahy B,Meek P,Wang A .2019 .Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med, 199(1) : P1-P2.
Mohan A,Arora S,Uniyal A,Poulose R,Luthra K,Pandey RM,Guleria R. .2017 .Evaluation of plasma leptin, tumor necrosis factor-α and prealbumin as prognostic biomarkers during clinical recovery from acute exacerbations of chronic obstructive pulmonary disease. Lung India, 34(1) : 3-8.
Mosrane Y,Bougrida M,Alloui AS,Martani M,Rouabah L,Bourahli MK,Mehdioui H,Ben Saad H H .2017 .Systemic inflammatory profile of smokers with and without COPD. Rev. Pneumol. Clin., 3(4) : 188-198.
Papi A,Vestbo J,Fabbri L,Corradi M,Prunier H,Cohuet G,Guasconi A,Montagna I,Vezzoli S,Petruzzelli S,Scuri M,Roche N,Singh D. .2018 .Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): A double-blind, parallel group, randomised controlled trial. Lancet, 391(10125) : 1076-1084.
Poole P,Sathananthan K,Fortescue R K .2019 .Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst. Rev., 5(5) : CD001287.
Prieto-Lloret J,Ramirez M,Olea E,Moral-Sanz J,Cogolludo A,Castañeda J,Yubero S,Agapito T,Gomez-Niño A,Rocher A,Rigual R,Obeso A,PerezVizcaino F and González C. .2015 .Hypoxic pulmonary vasoconstriction, carotid body function and erythropoietin production in adult rats perinatally exposed to hyperoxia. J. Physiol., 593(11) : 2459-2477.
Prudente R,Franco EAT,Mesquita CB,Ferrari R,de Godoy I,Tanni SE .2018 .Predictors of mortality in patients with COPD after 9 years. Int. J. Chron. Obstruct. Pulmon. Dis., 13 : 3389-3398.
Rabe KF,Watz H. .2017 .Chronic obstructive pulmonary disease. Lancet., 389(10082) : 1931-1940.
Sala E,Balaguer C,Villena C,Ríos A,Noguera A,Núñez B,Agustí A .2010 .Low erythropoietin plasma levels during exacerbations of COPD. , 80(3) : 190-197.
Schumann C,Triantafilou K,Krueger S,Hombach V,Triantafilou M,Becher G,Lepper PM .2006 .Detection of erythropoietin in exhaled breath condensate of nonhypoxic subjects using a multiplex bead array. Mediators Inflamm, : 18061.
Sharma RK,Chakrabarti S RK .2016 .Anaemia secondary to erythropoietin resistance: important predictor of adverse outcomes in chronic obstructive pulmonary disease. Postgrad Med, 92(1093) : 636-639.
Sosnin DY,Khovaeva YB,Podyanova AI,Syromyatnikova TN,Nenasheva OY .2018 .[Eritropoetin as laboratory index of the degree of respiratory insufficiency in chronic obstructive pulmonary diseases]. Klin, 63(11) : 691-695.
0

Citations

0

Downloads

12

Views